ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryFinance & InsuranceFunds & Investment CompaniesBaarSwixx Biopharma AG
Swixx Biopharma AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Swixx Biopharma AG is a pharmaceutical company that provides commercialization, regulatory, market access and pharmacovigilance services to international healthcare companies to introduce their products in selected markets. It operates across Central and Eastern Europe and other regions (including MENAT, Latin America and CIS) and does not conduct its own R&D or manufacturing.

AI-generated
Offering

Products & services

Industry:Funds & Investment Companies
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Swixx Biopharma AG

✓ Offered10
Commercialization platform for biopharma partners
Commercialization platform for multinational biopharma companies in non-core markets, covering market entry, commercial execution, medical support, regulatory activities and distribution.
Market Access & Pricing
National price filings, reimbursement dossiers, pharmacoeconomic model localization, and pricing and reimbursement negotiations for partner products.
Commercial
Brand-strategy transfer, medico-marketing activities, omnichannel customer engagement capabilities, and sales force effectiveness support across markets.
Medical
Scientific exchange with societies and healthcare professionals, partner medical strategy support, training, diagnosis support, and named-patient or compassionate-use access programs where permitted.
Medical Information
Responses to healthcare professionals’ and patients’ enquiries in line with regulatory, legal and ethical standards, tailored to partner requirements.
Regulatory
Product registration and maintenance services in line with local legislation across the product lifecycle for therapies handled by Swixx.
Pharmacovigilance
Local pharmacovigilance management, LPPV support, PV system master file maintenance, QPPV office support and fulfillment of pharmacovigilance obligations.
Quality
Quality management system, compliance with GDP, GMP, GVP, ISO standards, audits, wholesale licensing and GMP-licensed secondary packing activities.
Supply
Supply chain services from Ljubljana, including road and air freight, ambient and cold-chain transport, deep-freeze storage, local warehouses and secondary packaging.
Therapeutic area portfolio development
Launch and commercialization support for innovative therapies in rare disease, oncology/hematology, specialty care and vaccines, with some consumer healthcare products in limited territories.
Trust & reputation

ranQ Trust Score of Swixx Biopharma AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

Swixx Biopharma AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Swixx Biopharma AG scores 92.2 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.95.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.90.07%
Swixx Biopharma AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Swixx Biopharma AG scores 65.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.30.04%
Qualifications+0.00

Swixx Biopharma AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

December 15, 2025Media
SK Capital acquires majority stake in Swixx Biopharma at EUR 1.5 billion valuation
startupticker.ch
May 24, 2024Media
Following a strategic acquisition, Swixx BioPharma expects a turnover exceeding one billion
startupticker.ch

Knowledge

No knowledge articles yet

Once Swixx Biopharma AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Swixx Biopharma AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Swixx Biopharma AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Swixx Biopharma AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Neuhofstrasse 5A
6340 Baar

At a glance

Legal form
Corporation
UID
CHE-147.465.430
Founded
2013 · 13 years
Last commercial register change
June 12, 2026
Employees
51 to 100
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    GP
    Geneva Project Partners AG, Baar
    Baar
    AA
    ANREPA Asset Management AG
    Baar
    RS
    RealUnit Schweiz AG
    Baar
    IP
    iAccess Partners AG
    Baar
    DW
    DP World Global Forwarding Switzerland GmbH
    Baar
    MA
    MET Asset Management Holding AG
    Baar
    JS
    John Street Capital AG
    Zug
    VS
    Varia Swiss Realtech Properties AG
    Zug